Novartis: This big pharmaceutical giant could be a central holding company to sleep at night for decades
Novartis (NYSE: NVS) is a major Swiss pharmaceutical company with a market capitalization of over $300 billion. His areas of focus are extensive, covering oncology, immunology, neuroscience, respiratory care, and cardiovascular, renal and metabolic diseases. With a strong operating history and diversified business, The pharmaceutical giant could be an attractive stock for more conservative investors….